Creative Biolabs is a CRO working dedicatedly in the field of new drug discovery and is famous for its one-stop solution, covering the fundamental preclinical drug discovery pipeline initiating from target identification all the way to PK and PD validations. Since the outbreak of SARS-CoV-2 in 2019, Creative Biolabs has been keeping a close eye on the epidemic trend, actively reacting to any new emerging variant, aiming to provide the most up-to-date strategies for its customers working on antiviral drug discovery. A group of scientists from Creative Biolabs is participating in the Antibody Engineering & Therapeutics (US) 2022 in December, where their specialty in antibody discovery, engineering, and manufacturing will be presented.